151 related articles for article (PubMed ID: 28379666)
1. SCUBE1: a promising biomarker in renal cell cancer.
Karagüzel E; Menteşe A; Kazaz İO; Demir S; Örem A; Okatan AE; Altay DU; Yaman SÖ
Int Braz J Urol; 2017; 43(4):638-643. PubMed ID: 28379666
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase IX as a specific biomarker for clear cell renal cell carcinoma: comparative study of Western blot and immunohistochemistry and implications for diagnosis.
Giménez-Bachs JM; Salinas-Sánchez AS; Serrano-Oviedo L; Nam-Cha SH; Rubio-Del Campo A; Sánchez-Prieto R
Scand J Urol Nephrol; 2012 Oct; 46(5):358-64. PubMed ID: 22571179
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic significance of CA IX and suPAR in gastric cancer.
Fidan E; Mentese A; Ozdemir F; Deger O; Kavgaci H; Caner Karahan S; Aydin F
Med Oncol; 2013 Jun; 30(2):540. PubMed ID: 23512428
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers predicting outcome in patients with advanced renal cell carcinoma: Results from sorafenib phase III Treatment Approaches in Renal Cancer Global Evaluation Trial.
Peña C; Lathia C; Shan M; Escudier B; Bukowski RM
Clin Cancer Res; 2010 Oct; 16(19):4853-63. PubMed ID: 20651059
[TBL] [Abstract][Full Text] [Related]
5. The Diagnostic Value of FNDC5/Irisin in Renal Cell Cancer.
Altay DU; Keha EE; Karagüzel E; Menteşe A; Yaman SO; Alver A
Int Braz J Urol; 2018; 44(4):734-739. PubMed ID: 29522296
[TBL] [Abstract][Full Text] [Related]
6. Plasmatic carbonic anhydrase IX as a diagnostic marker for clear cell renal cell carcinoma.
Lucarini L; Magnelli L; Schiavone N; Crisci A; Innocenti A; Puccetti L; Cianchi F; Peri S; Supuran CT; Papucci L; Masini E
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):234-240. PubMed ID: 29251173
[TBL] [Abstract][Full Text] [Related]
7. The combined serum levels of miR-375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer.
Wach S; Al-Janabi O; Weigelt K; Fischer K; Greither T; Marcou M; Theil G; Nolte E; Holzhausen HJ; Stöhr R; Huppert V; Hartmann A; Fornara P; Wullich B; Taubert H
Int J Cancer; 2015 Sep; 137(6):1406-16. PubMed ID: 25754273
[TBL] [Abstract][Full Text] [Related]
8. Signal peptide-CUB-EGF domain-containing protein 1 (SCUBE1) level in hemodialysis patients and parameters affecting that level.
Ulusoy S; Ozkan G; Menteşe A; Yavuz A; Karahan SC; Sümer AU
Clin Biochem; 2012 Nov; 45(16-17):1444-9. PubMed ID: 22874483
[TBL] [Abstract][Full Text] [Related]
9. Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials.
Zhou GX; Ireland J; Rayman P; Finke J; Zhou M
Urology; 2010 Feb; 75(2):257-61. PubMed ID: 19963243
[TBL] [Abstract][Full Text] [Related]
10. Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer.
Li G; Feng G; Gentil-Perret A; Genin C; Tostain J
J Urol; 2008 Aug; 180(2):510-3; discussion 513-4. PubMed ID: 18550116
[TBL] [Abstract][Full Text] [Related]
11. Carbonic Anhydrase IX is not a predictor of outcomes in non-metastatic clear cell renal cell carcinoma - a digital analysis of tissue microarray.
Zerati M; Leite KR; Pontes-Junior J; Segre CC; Reis ST; Srougi M; Dall'Oglio MF
Int Braz J Urol; 2013; 39(4):484-92. PubMed ID: 24054396
[TBL] [Abstract][Full Text] [Related]
12. The significance of serum urokinase plasminogen activation receptor (suPAR) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies.
Kaya S; Köksal I; Menteşe A; Sönmez M; Sümer A; Yıldırım SS; Yılmaz G
Int J Infect Dis; 2013 Nov; 17(11):e1056-9. PubMed ID: 23742830
[TBL] [Abstract][Full Text] [Related]
13. Circulating large extracellular vesicles carrying CA9 in the diagnosis and prognosis of clear-cell renal cell carcinoma.
Vergori L; Martinez MC; Bigot P
Clin Transl Med; 2021 Mar; 11(3):e358. PubMed ID: 33783991
[No Abstract] [Full Text] [Related]
14. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
Enocsson H; Wetterö J; Skogh T; Sjöwall C
Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of plasma signal peptide-Cub-Egf domain-containing protein-1 (SCUBE-1) in an experimental model of acute ischemic stroke.
Turkmen S; Eryigit U; Karaca Y; Mentese A; Sumer UA; Yulug E; Aksut N; Gazioglu S; Gunduz A
Am J Emerg Med; 2015 Feb; 33(2):262-5. PubMed ID: 25541225
[TBL] [Abstract][Full Text] [Related]
16. Prolyl hydroxylase-3 is a novel renal cell carcinoma biomarker.
Kim KH; Lee HH; Yoon YE; Na JC; Kim KS; Han WK
Investig Clin Urol; 2019 Nov; 60(6):425-431. PubMed ID: 31692952
[TBL] [Abstract][Full Text] [Related]
17. Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis.
Zimmermann HW; Koch A; Seidler S; Trautwein C; Tacke F
Liver Int; 2012 Mar; 32(3):500-9. PubMed ID: 22098627
[TBL] [Abstract][Full Text] [Related]
18. Soluble carbonic anhydrase IX is not an independent prognostic factor in human renal cell carcinoma.
Papworth K; Sandlund J; Grankvist K; Ljungberg B; Rasmuson T
Anticancer Res; 2010 Jul; 30(7):2953-7. PubMed ID: 20683038
[TBL] [Abstract][Full Text] [Related]
19. Is SCUBE 1 a new biomarker for gastric cancer?
Mentese A; Fidan E; Sumer AU; Karahan SC; Sonmez M; Altay DU; Kavgaci H; Alver A
Cancer Biomark; 2012; 11(5):191-5. PubMed ID: 23220851
[TBL] [Abstract][Full Text] [Related]
20. Development and confirmation of potential gene classifiers of human clear cell renal cell carcinoma using next-generation RNA sequencing.
Eikrem OS; Strauss P; Beisland C; Scherer A; Landolt L; Flatberg A; Leh S; Beisvag V; Skogstrand T; Hjelle K; Shresta A; Marti HP
Scand J Urol; 2016 Dec; 50(6):452-462. PubMed ID: 27739342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]